Back
Kura Oncology Vs. Fabrinet Industry Stock Comparison
Sell
14
KURA
Kura Oncology
Last Price:
$7.86
Seasonality Move:
-0.17%
Buy
58
FN
Fabrinet
Last Price:
$222.07
Seasonality Move:
3.45%
Sell
14
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
-
The current Kura Oncology [KURA] share price is $7.27. The Score for KURA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
KURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $7.27The current trend is relatively stagnant and KURA is experiencing buying pressure, which is a positive indicator for future bullish movement.
KURA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 41.6 | Sell |
Chaikin Money Flow: | 57559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
FN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 56.54 | Buy |
Chaikin Money Flow: | -19181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KURA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.36 | Sell |
20-day SMA: | 7.61 | Sell |
50-day SMA: | 7.88 | Sell |
200-day SMA: | 15.38 | Sell |
8-day EMA: | 7.36 | Sell |
20-day EMA: | 7.59 | Sell |
50-day EMA: | 8.41 | Sell |
200-day EMA: | 13.06 | Sell |
FN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 213.25 | Buy |
20-day SMA: | 210.77 | Buy |
50-day SMA: | 219.69 | Buy |
200-day SMA: | 232.6 | Sell |
8-day EMA: | 215.76 | Buy |
20-day EMA: | 212.3 | Buy |
50-day EMA: | 217.61 | Buy |
200-day EMA: | 221.89 | Buy |
Kura Oncology Earnings Growth & KURA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.29 per share, and an increase next year of $0.07 per share.
Fabrinet Earnings Growth & FN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.02 per share, an increase this year of $1.53 per share, and an increase next year of $1.34 per share.
Kura Oncology Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fabrinet Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |